MARKET

BBC

BBC

Virtus LifeSci Biotech Clinical Trls ETF
NYSEARCA
28.16
-0.37
-1.28%
Closed 16:00 02/03 EST
OPEN
28.52
PREV CLOSE
28.53
HIGH
28.52
LOW
28.16
VOLUME
2.99K
TURNOVER
8.72K
52 WEEK HIGH
31.68
52 WEEK LOW
17.77
TOTAL ASSET
16.89M
YTD YIELD
-0.38%
1D
5D
1M
3M
1Y
5Y
Healthy Outlook For Therapeutics
Seeking Alpha · 01/25 08:36
Healthcare Stocks: An Innovative Antidote For Volatile Times
Seeking Alpha · 01/12 05:30
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha · 01/11 23:09
Genomic & Biotech ETFs pop, including Cathie Wood’s ARKG
Biotechnology and genomics-based exchange traded funds like the Genomics &amp; Biotechnology ETF (NASDAQ:<a href="https://seekingalpha.com/symbol/GNOM?utm_medium=referral&utm_source=webull.com" title="Global X F...
Seekingalpha · 08/03/2022 16:07
Deutsche Bank’s DWS Sees More Outflows in the Second Quarter
Bloomberg · 07/27/2022 06:41
Cathie Wood-Linked ETFs Are Standing Out From $6.4 Trillion Pack
Bloomberg · 07/26/2022 19:38
Gig-Economy ETF Rebrands as BYOB in Bid to Gain Attention
Bloomberg · 07/26/2022 17:57
New Single-Stock ETFs Are ‘Recipe For Disaster,’ Experts Say
Bloomberg · 07/26/2022 14:30
More
Profile
Fund Name
Virtus LifeSci Biotech Clinical Trls ETF
Inception Date
2014-12-16
Benchmark
LifeSci Biotech Clinical Trials USD
Advisor Company
Virtus ETF Advisers LLC
Custodian
Bank of New York Mellon
Manager
Matthew Brown, Seth Kadushin